Cargando…
Expression of survivin, a novel inhibitor of apoptosis and cell cycle regulatory protein, in pancreatic adenocarcinoma
Survivin is unique for its expression in human malignancies but not in normal adult cells. It has been implicated in sensitisation to chemotherapy and as a prognostic marker in several common cancers. Immunohistochemistry for Survivin, P53 and BCL-2 expression as well as cell proliferative index (Ki...
Autores principales: | Sarela, A I, Verbeke, C S, Ramsdale, J, Davies, C L, Markham, A F, Guillou, P J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364160/ https://www.ncbi.nlm.nih.gov/pubmed/11953819 http://dx.doi.org/10.1038/sj.bjc.6600133 |
Ejemplares similares
-
Expression of different survivin variants in gastric carcinomas: first clues to a role of survivin-2B in tumour progression
por: Krieg, A, et al.
Publicado: (2002) -
Survivin expression in oral squamous cell carcinoma
por: Muzio, L Lo, et al.
Publicado: (2003) -
Prognostic importance of survivin in breast cancer
por: Kennedy, S M, et al.
Publicado: (2003) -
Increased expression of survivin in gastric cancer patients and in first degree relatives
por: Yu, J, et al.
Publicado: (2002) -
Heparanase expression is a prognostic indicator for postoperative survival in pancreatic adenocarcinoma
por: Rohloff, J, et al.
Publicado: (2002)